Assignee
KERYX BIOPHARMACEUTICALS INC
US·1 granted patent·19 pending applications·0 citations·filing 2002–2024
Top patents by PatentIndex Score
20 records- 0171US2025144064A1Ferric citrate dosage formsKERYX BIOPHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0259US2025360167A1Use of ferric citrate in the treatment of and the reduction of mortality and morbidity related to adverse cardiac events in chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0358US2020215019A1Ferric citrate dosage formsKERYX BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0456US2024100011A1Pediatric formulations of ferric citrateKERYX BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0555US2020297689A1Ferric citrate dosage formsKERYX BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0648US2024075006A1Use of ferric citrate in the treatment of iron-deficiency anemiaKERYX BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0745US2013274328A1Ferric citrate dosage formsKERYX BIOPHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0844US10300039B2Ferric citrate dosage formsKERYX BIOPHARMACEUTICALS INC·Filed 2016·Granted May 28, 2019·0 cites·17 claims
- 0944US2014234416A1Use of ferric citrate in the treatment of chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1041US2005209188A1Methods using glycosaminoglycans for the treatment of nephropathyKERYX BIOPHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1141US2013345303A1Use of ferric citrate in the treatment of chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1240US2024041816A1Use of ferric citrate in the treatment of chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1335US2016256486A1Use of ferric citrate in the treatment of and the reduction of mortality and morbidity related to adverse cardiac events in chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1435US2015079168A1Use of ferric citrate in the treatment of chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1534US2019307791A1Use of ferric citrate in the treatment of and the reduction of mortality and morbidity related to adverse cardiac events in chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1633US2007173479A1Methods Using Sulodexide for the Treatment of Bladder DiseaseKERYX BIOPHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1733US2003078400A1Compounds for the modulation of kinase associated signal transductionKERYX BIOPHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 1829US2003008844A1Use of sulodexide for the treatment of inflammatory bowel diseaseKERYX BIOPHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 1927US2019269645A1Use of ferric citrate in the treatment of chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2021US2018071243A1Use of ferric citrate in the treatment of iron-deficiency anemiaKERYX BIOPHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KERYX BIOPHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →